TOLEDO, Ohio (WTVG) – A Toledo patient was part of a clinical trial aimed at treating brain bleeds with the goal of avoiding repeat surgeries. The EMBOLISE clinical trial tested whether a new treatment for subdural hematomas, which are brain bleeds most frequently caused by trauma, and is the most common reason for neurosurgery, would lead to lower chances of requiring additional surgery.